As a non-profit organization dedicated to finding a cure for children suffering from Tuberous Sclerosis Complex (TSC), The Rothberg Institute For Childhood Diseases (TRI) seeks out and utilizes the most powerful and proven technology solutions. Through affiliations with companies like Sengent, their extensive network of premier scientists and physicians can employ cutting-edge technologies including cell based high content screening, ultra high throughput screening systems, bioinformatics and robotics.

Clarifi has focused on exploring ways to apply their distributed computing technology to improving the cost and performance of drug discovery. This technology team places the appropriate mix of powerful and reliable traditional and emerging technologies at TRI’s disposal while allowing the foundation to focus on the science at hand and make every research dollar count towards finding cures for TSC.

this page last reviewed